• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

1.620 -0.170 (-9.50%)
Official Closing Price Updated: 8:00 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Liquid Biopsy Forecasts Response to Immunotherapy in Lung Cancer Patients
August 06, 2026
Via Investor Brand Network
Existing Immune Protein May Boost Immunotherapy Against Cancer
August 05, 2026
Via Investor Brand Network
Researchers Plan to Investigate Role of Autoantibodies in Cancer Risk, Immune Response
July 28, 2026
Via Investor Brand Network
Dietary Fat Balance Could Influence Immune System Function, Study Finds
July 22, 2026
Via Investor Brand Network
Study Links Gut Microbial Metabolites to Enhanced Cancer Immunotherapy Sensitivity
July 17, 2026
Via Investor Brand Network
Understanding Why Treatment Resistance Exists in Many Cancers
July 09, 2026
Via Investor Brand Network
Biomarkers Could Predict Patients’ Response to Bladder Cancer Therapy
June 17, 2026
Via Investor Brand Network
AI Tool Predicts the Optimal Presurgical Treatments for Breast Cancer
July 08, 2026
Via Investor Brand Network
Topics Artificial Intelligence
Comprehensive Review Shows Gut Microbiome Influences Immunotherapy Efficacy
July 02, 2026
Via Investor Brand Network
Currently Approved Drug Could Boost Immunotherapy Against Liver Cancer
June 30, 2026
Via Investor Brand Network
Why Men Need Sexual Health Help While Undergoing Cancer Treatment
June 22, 2026
Via Investor Brand Network
FIU Researchers Discover New Way of Extending Immune Cell Lifespan and Effectiveness
June 11, 2026
Via Investor Brand Network
News headline image
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on June 9
June 05, 2026
Via ACCESS Newswire
New Pill Offers Hope Against Pancreatic Cancer
June 03, 2026
Via Investor Brand Network
New Inhalable Agent Could Improve Treatment Outcomes in Lung Cancer
June 02, 2026
Via Investor Brand Network
Scientists Inch Closer to Developing a Lung Cancer Blood Test
May 21, 2026
Via Investor Brand Network
Researchers Create Less Toxic, More Effective Immunotherapy Against Blood Cancer
May 20, 2026
Via Investor Brand Network
NHS Starts Offering Immunotherapy Injection to Cancer Patients
May 12, 2026
Via Investor Brand Network
Study Suggests Timing of Immunotherapy Could Impact Clinical Outcomes
May 11, 2026
Via Investor Brand Network
Study Finds That Vitamin D Supercharges Chemotherapy Against Breast Cancer
May 04, 2026
Via Investor Brand Network
Study Uncovers Why the Risk of Breast Cancer Increases with Age
May 01, 2026
Via Investor Brand Network
Early Trial Suggests mRNA Vaccine Could Be Effective Against Pancreatic Cancer
April 22, 2026
Via Investor Brand Network
News headline image
RedChip's Biotech Virtual Investor Conference Replays Now Available
April 21, 2026
Via ACCESS Newswire
New AI Tool Could Boost the Early Detection of Lung Cancer
April 16, 2026
Via Investor Brand Network
Topics Artificial Intelligence
New Urine Test Boosts Forecasting of Treatment Outcomes in Bladder Cancer
April 13, 2026
Via Investor Brand Network
Immunotherapy Could Be Boosted by Blocking the Removal of Cancer RNA
April 10, 2026
Via Investor Brand Network
News headline image
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
April 07, 2026
Via ACCESS Newswire
Report Forecasts the Cancer Immunotherapy Market Hitting $311.4B by 2031
April 02, 2026
Via Investor Brand Network
Research Suggests the Thymus is Critical in Immunotherapy Outcomes
March 30, 2026
Via Investor Brand Network
Topics Artificial Intelligence
Major Discovery Could Reshape Cancer Immunotherapy
March 27, 2026
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap